ROCKVILLE, Md., Dec. 11, 2015 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) announced today the retirement of its Executive Director Sherry Keramidas whose leadership during a 20-year tenure helped advance the healthcare regulatory profession. She will retire on 31 January 2016.
"Sherry has served RAPS and its members during a critical period of change in the healthcare industry," according to RAPS Chairman of the Board Rainer Voelksen. "Her constancy throughout ensured RAPS' mission to provide leading education and professional development opportunities and credentialing to regulatory professionals. The RAPS Board of Directors extends its deepest appreciation to Sherry for her two decades of stewardship and commitment to RAPS members, partners and Board."
"It's been my pleasure to serve RAPS during a period of unprecedented change in the healthcare industry," said Keramidas. "The regulatory environment will continue to rapidly evolve and I retire from RAPS confident that the advancement of its professionals will continue to be the defining commitment of this organization's leadership."
The Board's top priority during the transition to new leadership is to ensure RAPS' continuity in fulfilling day-to-day operations that deliver on the organization's commitment to programming and other essential functions that serve its members and partners. Sherry will help facilitate the transition by working with the Executive Committee of the Board to provide support on specific key initiatives.
The Board has initiated a search for a new executive director and will be announcing a plan for interim leadership in the coming weeks. It has established a Search Committee of the Board and will engage a professional recruiting firm to conduct the search for the permanent executive director.
With questions or for more information, please contact RAPS President Martha A. Brumfield at [email protected].
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245; [email protected]


SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 



